Depuis le démarrage de notre activité de capital - investissement en 1989, nous avons investi dans plus de 335 sociétés réparties dans 40 pays.
| Société | Pays | Secteur | Description | Type de deal | Date de l'investissement | |
|---|---|---|---|---|---|---|
 |
Simtra BioPharma Solutions
|
Pays United States | Secteur Santé | Description Leading provider of sterile contract manufacturing solutions, parenteral delivery systems and customized support services to the pharmaceutical and biotech industries | Type de deal Détourage | Date de l'investissement Sep 2023 |
 |
Suven Pharmaceuticals
|
Pays India | Secteur Santé | Description A leader in the India pharma CDMO space | Type de deal Other | Date de l'investissement Sep 2023 |
 |
GS Capsule
|
Pays Greater China | Secteur Santé | Description A leading research, development and production company of hard capsules in China | Type de deal Buyout | Date de l'investissement Dec 2021 |
 |
Iodine Software
|
Pays United States | Secteur Healthcare; Technology | Description A leading healthcare AI company | Type de deal Growth equity | Date de l'investissement Nov 2021 |
 |
RxBenefits
|
Pays United States | Secteur Santé | Description A pharmacy benefits optimization platform that delivers cost savings, clinical solutions, and customer service to small and mid-sized self-funded employer groups | Type de deal Recapitalization | Date de l'investissement Dec 2020 |
 |
Cohance Lifesciences (formerly RA Chem Pharma Limited)
|
Pays India | Secteur Santé | Description A vertically integrated API player, also engaged in manufacturing of pellets, B2B formulations and clinical studies | Type de deal Buyout | Date de l'investissement Oct 2020 |
 |
Bharat Serums and Vaccines
|
Pays India | Secteur Santé | Description A biopharmaceutical leader in women's healthcare, assisted reproductive treatment, critical care and emergency medicine in India and emerging markets | Type de deal Buyout | Date de l'investissement Feb 2020 |
 |
ICE Pharma
|
Pays Italy | Secteur Santé | Description A global leader in the production of Ursodeoxycholic Acid (UDCA) used for the treatment of gastric and chronic diseases | Type de deal Buyout | Date de l'investissement Sep 2019 |
 |
Donte Group (formerly Vitaldent)
|
Pays Spain | Secteur Santé | Description Leading dental services provider in Spain | Type de deal Buyout | Date de l'investissement Sep 2019 |
 |
AccentCare
|
Pays United States | Secteur Santé | Description Nationwide leader in post-acute healthcare | Type de deal Buyout, Growth equity | Date de l'investissement Jun 2019 |
 |
BioDuro
|
Pays China | Secteur Santé | Description A leading global life sciences contract research and development organization | Type de deal Buyout | Date de l'investissement Jan 2019 |
 |
Zentiva
|
Pays Czech Republic | Secteur Santé | Description A leading European generics pharmaceutical company, offering generic medicines across all key therapeutic areas | Type de deal Détourage | Date de l'investissement Sep 2018 |
 |
Deutsche Fachpflege Gruppe, (“DFG”)
|
Pays Germany | Secteur Santé | Description Germany's largest outpatient intensive care provider | Type de deal Buyout | Date de l'investissement Jul 2018 |
 |
Grupo Farmaceutico Somar
|
Pays Mexico | Secteur Santé | Description Leading pharmaceutical company focused on the development, manufacture and marketing of high-quality generic and branded generic products in Mexico | Type de deal Détourage | Date de l'investissement Oct 2017 |
 |
Syneos Health, Inc. (formerly INC Research Holdings, Inc.)
|
Pays United States | Secteur Santé | Description A global provider of outsourced clinical development and commercialization services to biopharmaceutical companies | Type de deal Buyout | Date de l'investissement Nov 2016 |
 |
ATI Physical Therapy Holdings, LLC
|
Pays United States | Secteur Santé | Description A leading outpatient physical therapy provider in the United States | Type de deal Buyout | Date de l'investissement May 2016 |
 |
Fleury S.A.
|
Pays Brazil | Secteur Santé | Description The largest provider of premium medical diagnostic services in Brazil | Type de deal PIPE | Date de l'investissement Oct 2015 |
 |
Genoa Healthcare
|
Pays United States | Secteur Santé | Description Largest specialty pharmacy operator in the US focusing primarily on serving the needs of the mental health community | Type de deal Buyout | Date de l'investissement Apr 2015 |
 |
Mediq
|
Pays Netherlands | Secteur Santé | Description Global provider of pharmaceuticals, medical devices and related care services | Type de deal Public-to-private | Date de l'investissement Feb 2013 |
 |
Cotiviti
|
Pays United States | Secteur Santé | Description A leading payment accuracy provider | Type de deal Buyout | Date de l'investissement Jul 2012 |
 |
CARE Hospitals
|
Pays India | Secteur Santé | Description Largest multi-specialty hospital chain in South and Central India | Type de deal Growth equity | Date de l'investissement Mar 2012 |
 |
Grupo Biotoscana
|
Pays Colombia | Secteur Santé | Description Specialty pharmaceutical company licensing innovative and niche products to market in Latin America | Type de deal Buyout | Date de l'investissement Nov 2011 |
 |
American Heart of Poland
|
Pays Poland | Secteur Santé | Description A leading operator of cardiovascular treatment clinics in Poland | Type de deal Growth equity | Date de l'investissement Oct 2011 |
 |
Laboratorio LKM
|
Pays Argentina | Secteur Santé | Description One of the leading specialty pharmaceutical manufacturers in Argentina | Type de deal Buyout | Date de l'investissement Oct 2011 |
 |
Isida
|
Pays Ukraine | Secteur Santé | Description One of Ukraine's leading medical treatment and healthcare providers | Type de deal Buyout | Date de l'investissement Mar 2011 |
 |
Regina Maria (formerly Centrul Medical Unirea)
|
Pays Romania | Secteur Santé | Description Leading premium integrated private healthcare services operator in Romania | Type de deal Buyout | Date de l'investissement Feb 2010 |
 |
MEDIAN
|
Pays Germany | Secteur Santé | Description Leading independent rehabilitation care provider in Germany | Type de deal Buyout | Date de l'investissement Oct 2009 |
 |
Craegmoor
|
Pays United Kingdom | Secteur Santé | Description A leading UK provider of specialist care for adults and younger people (acquired by Advent portfolio company The Priory Group) | Type de deal Buyout | Date de l'investissement Jul 2008 |
 |
The Priory Group
|
Pays United Kingdom | Secteur Santé | Description The UK's leading independent provider of mental health and specialist care services | Type de deal Détourage | Date de l'investissement Jul 2008 |
 |
Labormed
|
Pays Romania | Secteur Santé | Description Romanian pharmaceutical manufacturer and distributor | Type de deal Buyout | Date de l'investissement Feb 2008 |
 |
Casa Reha
|
Pays Germany | Secteur Santé | Description One of the leading German private nursing home groups | Type de deal Buyout, Secondary buyout | Date de l'investissement Sep 2005, Jan 2008 |
 |
Terapia
|
Pays Romania | Secteur Santé | Description Romania's largest independent generic pharmaceuticals manufacturer | Type de deal Public-to-private | Date de l'investissement Aug 2003 |
 |
Aviagen
|
Pays United Kingdom | Secteur Santé | Description World's leading meat poultry breeding company | Type de deal Buyout | Date de l'investissement May 2003 |
 |
American Radiology Services
|
Pays United States | Secteur Santé | Description Regional provider of fully integrated diagnostic imaging services | Type de deal Buyout | Date de l'investissement Mar 2003 |
 |
Viatris
|
Pays Germany | Secteur Santé | Description Development, manufacturing, distribution and in-licensing of branded pharmaceuticals | Type de deal Détourage | Date de l'investissement Aug 2002 |
 |
Fada Pharma
|
Pays Argentina | Secteur Santé | Description Argentina's leading manufacturer of generic pharmaceuticals for the institutional market | Type de deal Buyout | Date de l'investissement Jan 2001 |
 |
Tropon
|
Pays Germany | Secteur Santé | Description Toll manufacturer and supplier of drugs for inflammatory and rheumatoid disorders (acquired by Advent portfolio company Viatris) | Type de deal Détourage | Date de l'investissement Mar 2000 |
 |
Alcala Farma
|
Pays Spain | Secteur Santé | Description Manufacturer and marketer of own and in-licensed pharmaceuticals, branded generics and over-the-counter products | Type de deal Growth equity | Date de l'investissement Sep 1999 |
 |
Americus Dental Labs
|
Pays United States | Secteur Santé | Description Full-service dental laboratory offering restorative, reconstructive and cosmetic products to dentists | Type de deal Growth equity | Date de l'investissement Dec 1997 |
|
Ciraden (formerly MainStreet Dental Management)
|
Pays United States | Secteur Santé | Description Dental management service organization | Type de deal Growth equity | Date de l'investissement Dec 1997 |
 |
National PetCare Centers
|
Pays United States | Secteur Santé | Description Network of veterinary hospitals | Type de deal Growth equity | Date de l'investissement Oct 1997 |
 |
Managed Healthcare Associates
|
Pays United States | Secteur Santé | Description Provider of contract purchasing services to long-term-care pharmacies | Type de deal Buyout | Date de l'investissement Oct 1997 |
 |
Trinity Pharmaceuticals
|
Pays United Kingdom | Secteur Santé | Description Co-development, licensing and marketing of branded pharmaceuticals, mainly for cardiovascular and arthritic indications | Type de deal Détourage | Date de l'investissement Mar 1997 |
 |
Physicians' Online
|
Pays United States | Secteur Santé | Description Provider of online medical information and communication services to physicians | Type de deal Growth equity | Date de l'investissement Feb 1996 |
 |
3i - Implant Innovations Inc.
|
Pays United States | Secteur Santé | Description Manufacturer of dental implants | Type de deal Growth equity | Date de l'investissement May 1995 |
 |
Telik
|
Pays United States | Secteur Santé | Description Developer of novel pharmaceuticals to treat cancer and metabolic diseases (merged with MabVax Therapeutics) | Type de deal Growth equity | Date de l'investissement Nov 1994 |
 |
Esaote Biomedica
|
Pays Italy | Secteur Santé | Description Research, production and marketing of imaging and non-imaging medical diagnostic equipment | Type de deal Privatization | Date de l'investissement Jul 1994 |
 |
Thonburi Hospital
|
Pays Thailand | Secteur Santé | Description Hospital providing general medical care, surgery, intensive care, cardiac care, x-ray and laboratory services | Type de deal Growth equity | Date de l'investissement Jul 1994 |
 |
Transcend Therapeutics
|
Pays United States | Secteur Santé | Description Company formed to develop novel pharmaceuticals for the critical-care market | Type de deal Growth equity | Date de l'investissement Apr 1994 |
|
Greenacre
|
Pays United Kingdom | Secteur Santé | Description Owner and operator of residential care facilities and nursing homes | Type de deal Growth equity | Date de l'investissement Nov 1990 |
© 2002-2024 Advent International, L.P. All rights reserved
